Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for BUPRENORPHINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 38
  • 0 comments

Labeling changes approved for AM REGENT. Active ingredient: BUPRENORPHINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for METHADONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 50
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: METHADONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for METHADONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 41
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: METHADONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 53
  • 0 comments

Labeling changes approved for INTL MEDICATION. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 54
  • 0 comments

Labeling changes approved for PHARMOBEDIENT. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for BUPRENORPHINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 37
  • 0 comments

Labeling changes approved for HOSPIRA. Active ingredient: BUPRENORPHINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for HYDROCODONE BITARTRATE AND IBUPROFEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 41
  • 0 comments

Labeling changes approved for AMNEAL PHARMS NY. Active ingredient: HYDROCODONE BITARTRATE; IBUPROFEN. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for NALBUPHINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 58
  • 0 comments

Labeling changes approved for HOSPIRA. Active ingredient: NALBUPHINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for MEPERIDINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 55
  • 0 comments

Labeling changes approved for SUN PHARM INDUSTRIES. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for METHADONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 43
  • 0 comments

Labeling changes approved for EPIC PHARMA LLC. Active ingredient: METHADONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text
  • Previous
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328515)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183557)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin